glp-1 nobel prize At the 2025 Breakthrough Ceremony, Dr. Lotte Bjerre Knudsen of Novo Nordisk was honored with the Breakthrough Prize in Life Sciences for her contributions to the development of GLP-1–based Who should win a Nobel

GCGR/GLP-1R agonist: OR: 0.44, 95%CI: 0.350.55, P = 1.22 10 12

GLP-1 Analoglarnn Temel Faydalar 1

Why MeAgain Is the Stronger WeightWatchers GLP-1 Alternative for Daily Tracking A GLP-1-first app, whatever your care path The biggest difference between MeAgain and WeightWatchers GLP-1 is not the medication question

I never imagined Id lose 221 poundsor find peace in the process

Journal of Sexual Medicine / PMC Clinical review: how GLP-1 obesity medications may decrease sexual desire PMC (NIH) Anorgasmia following initiation of a GLP-1 agonist PLOS One / PMC Weight loss, testosterone, SHBG, and erectile function in overweight and obese men Andrologia (meta-analysis) Effect of weight loss on erectile function in men with overweight or obesity PubMed Sexual Function, Obesity, and Weight Loss in Men and Women PMC (NIH) / Healthcare Hormonal profile, weight, and sexual function in women with PCOS Indiana University, Kinsey Institute Survey on GLP-1s, sex, and dating

Your healthcare provider will help you choose the best option based on factors like: Your medical history and current health status Your weight loss goals Your risk of potential side effects Your insurance coverage and ability to access the medication The availability of compounded versions, which may offer cost savings However, its always important to discuss the pros and cons of compounded medications with your healthcare provider